This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Credit: SDSU For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.
Credit: Francesco Righetti Researchers at Karolinska Institutet in Sweden have come one step closer toward understanding why some people become seriously ill or die from a common bacterium that leaves most people unharmed.
A Faculty of Medicine team from the University of Ottawa and their international collaborators have shown proof of concept for an entirely new therapeutic approach in treating tuberculosis (TB), an enduring and recently accelerating scourge that is the leading cause of death worldwide by a bacterial infection.
Scientists have demonstrated that modifying an enzyme produced by the bacterium that causes anthrax can protect mice from infection with the deadly disease.
Work allows genomic monitoring for epidemic strains of Vibrio cholerae bacteria The evolution of epidemic and endemic strains of the cholera-causing bacterium Vibrio cholerae in Argentina has been mapped in detail by researchers at the Wellcome Sanger Institute, the London School of Hygiene and Tropical Medicine, the University of Cambridge and the (..)
Credit: University of Exeter Bioimaging Unit Scientists have discovered how bacteria commonly responsible for seafood-related stomach upsets can go dormant and then “wake up” Vibrio parahaemolyticus is a marine bacterium that can cause gastroenteritis in humans when eaten in raw or undercooked shellfish such as oysters and mussels.
In a new study, researchers have designed a miniaturized 3D-printed device to inactivate Pseudomonas aeruginosa, a common bacterium that causes the infection. Credit: Jungeun Won Middle ear infections, also known as otitis media, affect more than 80% of the children in the U.S.
Researchers have known for some time that maternal breast milk provides critical nutrients for newborns, and antibodies from mothers vaccinated against a specific disease-causing bacterium or virus can be transferred via breast milk to babies.
— Envisioning an animal-free drug supply, scientists have — for the first time — reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals. Process paves a road to safe, ethical, and fast drug manufacturing Credit: Rensselaer Polytechnic Institute TROY, N.Y.
Credit: UCSF Researchers at UCSF have found that extreme caloric restriction diets alter the microbiome in ways that could help with weight loss but might also result in an increased population of Clostridiodes difficile, a pathogenic bacterium that can lead to severe diarrhea and colitis.
of the University of Alabama at Birmingham have made what they call “a major step” in understanding how Mycobacterium tuberculosis acquires iron from its human host — a process essential for the pathogenesis of this bacterium. . – Lei Zhang, Ph.D., and Michael Niederweis, Ph.D.,
Researchers have produced vaccine-like immune responses to a dangerous bacterium by colonizing 26 healthy volunteers with a related, but harmless, commensal bacterial species.
Tuberculosis, a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), is typically the leading infectious cause of death globally, killing 1.2 million […].
A new clinical study has shown that supplements of a lactic acid bacterium may have positive effects by increasing the diversity of intestinal bacteria in these infants. Extremely preterm infants can suffer from a life-threatening inflammation of the gut.
Structural insights about a deadly bacterium’s toolbox point to ways to block it Credit: Maria Schumacher Lab, Duke Biochemistry DURHAM, N.C. – The bacterium that causes the tick-borne disease tularemia is a lean, mean infecting machine.
The disease – commonly known as the clap – was diagnosed in 82 million people in 2020 according to World Health organisation (WHO) estimates and ranks high among the agency’s infectious diseases of greatest concerns as it is rapidly becoming resistant to antimicrobial medicines.
The disease, caused by the tick-borne Borrelia bacterium, generally begins with a bull’s-eye–shaped rash on the skin, along with fever, headache, chills and […].
Amgen has decided that a drug for leprosy and tuberculosis it inherited as part of its acquisition of Celgene’s psoriasis blockbuster Otezla last year would fare better in the hands of a non-profit company, dedicated to bringing affordable medicines to poorer countries. million patients every year and causing over a million deaths.
diff is a bacterium that causes diarrhea, often with severe or […]. A new study from North Carolina State University shows that the inflammation caused by Clostridioides difficile (C. diff to thrive.
This syndrome refers to food poisoning caused by a bacterium called Bacillus cereus. As detailed in the National Library of Medicine , the individual encountered symptoms like headache, abdominal pain, nausea and diarrhea within half an hour of eating, and tragically passed away that night. Fried rice syndrome primarily stems from B.
The Medicines and Healthcare products Regulatory Agency’s (MHRA) gave a conditional approval to Idefirix – an enzyme derived from the bacterium Streptococcus pyogenes that breaks down immunoglobulin G (IgG) antibodies in the body – in 2020.
Everyone, no matter where they live, should have access to life-saving medicines. Trachoma is a neglected tropical disease (NTD) caused by the bacterium Chlamydia trachomatis. An estimated 1.9 million people suffer visual impairment because of infection, and women are up to four times more likely to be blinded by trachoma than men.
Substance requirement: A natural health product is a substance set out in Schedule 1 to the NHP Regulations (or a combination of such substances), a homeopathic medicine, or a traditional medicine.
billion in potential development milestones Proposed acquisition provides access to next-generation 24-valent pneumococcal vaccine candidate in phase II development and highly innovative, MAPS TM technology Supports development of a strong portfolio of innovative vaccines and specialty medicines. GSK to pay $2.1 billion upfront and up to $1.2
It is this bacterium that. You will want to know about these new discoveries. The Colon Diseases You Develop When. You Have Constipation. Your gut, which consists of your small intestine. and colon, is home for good and bad bacteria. sends energetic signals to all parts of your body to control their function. have, good or bad.
Medical Aesthetics is an area of modern medicine that specializes in improving the outer appearance of an individual without surgery. Medical aesthetic procedures can be broadly categorized into two categories, namely non-invasive and invasive. This treatment is primarily used on the face to weaken facial muscles, reducing wrinkles.
With each passing year, pharmaceutical companies around the globe strive to deliver cutting-edge medicines, therapies and vaccines that impact the lives of millions. In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine.
In a study published in Science Translational Medicine , researchers from Japan’s Nagoya University documented how Fusobacterium may play a key role in spurring the development of endometriosis.
A test designed by UCLA researchers can pinpoint which people with gonorrhea will respond successfully to the inexpensive oral antibiotic ciprofloxacin, which had previously been sidelined over concerns the bacterium that causes the infection was becoming resistant to it.
In addition to pharma and biotech companies who zealously began working to develop COVID-19 drugs and vaccines, companies from areas outside of science and medicine also stepped up to help during the pandemic. The study was published this month in the New England Journal of Medicine.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content